Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The NMDA receptor (N-methyl-D-aspartate receptor) is a subtype of ionotropic glutamate receptors, which are ligand-gated ion channels primarily responsible for mediating excitatory neurotransmission in the central nervous system. It is a heterotetrameric complex typically composed of two GluN1 subunits and two GluN2 or GluN3 subunits. Upon activation by glutamate and glycine, it acts as a nonselective cation channel allowing passage of Na+, K+, and Ca2+ ions. Its voltage-dependent block by Mg2+ ions makes it a coincidence detector critical for synaptic plasticity. Implicated in numerous neurological conditions including epilepsy, neurodegenerative diseases, and schizophrenia.
Ligand binding (glutamate and glycine) and membrane depolarization to relieve Mg2+ block, leading to ion channel opening and influx of Na+, K+, and Ca2+ ions.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glutamate Receptor Ionotropic, NMDA (NMDAR).